+987.9%
MRNA vs EXE
-18.4%
+1,006.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EXE | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -2.9% | +16.0% | +13.2% |
| 7D | +20.6% | -4.7% | +25.3% | +20.8% |
| 30D | +27.1% | +1.0% | +26.1% | +26.3% |
| 3M | +353.4% | -5.6% | +359.0% | +356.3% |
| 6M | +446.3% | -12.3% | +458.6% | +458.6% |
| YTD | +776.2% | -19.5% | +795.7% | +809.5% |
| 1Y | +987.9% | -18.9% | +1,006.8% | +975.1% |
| All | +987.9% | -18.4% | +1,006.4% | +975.1% |
Cumulative growth
Daily Returns
Daily percentage return beside EXE.
Daily Out/Under-Performance
Portfolio return minus EXE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EXE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EXE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling